2014 FDA Drug Approval Decision Calendar
TheStreet.com
- Alimera
- Amarin
- Anacor
- AstraZeneca
- Auxilium
- BioDelivery Sciences
- Biogen Idec
- Biomarin
- Bristol-Myers Squibb
- Celgene
- Chelsea Therapeutics
- Cubist Pharmaceuticals
- drug approvals
- Durata Therapeutics
- Eli Lilly
- FDA
- Gilead
- GSK
- JNJ
- Keryx
- MannKind
- Nektar
- Omeros
- Pharmacyclics
- Pozen
- pSivida
- Santarus
- Theravance
- United Therapeutics
- Vanda
Four Biotech 'Surprise' Stocks for 2014
TheStreet.com
Is This Cubist's Biggest Opportunity?
Motley Fool
Voluntary Recall at Cubist Pharma
Yahoo/Zacks
Trius Acquired Last Week, Tetraphase Could Be Next
Seeking Alpha